Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 14 - Sep 19
The growing research field of mitochondrial epigenetics shows, in particular, an interesting potential in CVD prevention, especially in association with other existing biomarkers whose meaning is still under investigation
is a leading plant extracts and herbal medicine manufacturer, located in Chang'an District, Xi'an, Shaanxi Province, China
GHK-Cu published research history: - First isolated and characterized: 1973 - Continuous peer-reviewed publication: 50+ years - Published research covering: wound healing, skin biology, COPD, oxidative stress, bone, skeletal muscle, gastrointestinal, neurological, gene expression, aging - Mechanistic characterization: Multiple pathways identified, SIRT1 direct binding confirmed in 2025 - Cell and animal model validation: Extensive across multiple tissue types and species Matrixyl 3000 (palmitoyl tripeptide-1 + palmitoyl tetrapeptide-7) research: - Commercial introduction: Early 2000s - Research base: Primarily cosmetic science and dermatology literature - Mechanistic characterization: Primarily focused on TGF-beta receptor and IL-6 pathways - Depth: Narrower tissue focus, smaller body of published mechanistic research For researchers who need a compound with extensive published mechanistic context, detailed gene expression data, or research across multiple tissue types, GHK-Cu's research depth is substantially greater
$107.67 x 3 meses sin intereses Acumula 4 y llvate 1 GRATIS con tu Monedero del Ahorro Precio habitual MXN $769.00 * Precio exclusivo de tienda en lnea
